Articles From: Dr Pepper Snapple Group Announces Appointment of Director to DRA CRT Acquisition Corp. Declares Quarterly Dividend on Preferred Stock


Dr Pepper Snapple Group, Inc. (NYSE: DPS) today announced that Dunia Shive has joined the company’s board of directors.
Sign-up for Dr Pepper Snapple Group Announces Appointment of Director investment picks
Dr Pepper Snapple Group, Inc. (NYSE: DPS) today announced that its Board of Directors declared a quarterly dividend of $0.41 per share on the company’s common stock.
Sign-up for Dr Pepper Snapple Group Declares Quarterly Dividend investment picks
Dr Pepper Snapple Group (NYSE:DPS) has again been named a member of The Civic 50 , an annual initiative that identifies and recognizes companies for their commitment to improving the quality of life in the communities where they operate.
Sign-up for Dr Pepper Snapple Group Recognized as a Top Community-Minded Company for Third Consecutive Year investment picks
Dr Pepper Snapple Group, Inc. (NYSE: DPS) reported third quarter 2014 EPS of $0.96 compared to $1.01 in the prior year period.
Sign-up for Dr Pepper Snapple Group Reports Third Quarter 2014 Results investment picks
Dr Pepper Snapple Group, Inc., (NYSE: DPS) will issue its third quarter 2014 financial results on Thursday, Oct.
Sign-up for Dr Pepper Snapple Group to Webcast Conference Call and Slide Presentation on Third Quarter 2014 Earnings investment picks
2014/10/23
Mercer has appointed Dr.
Sign-up for Dr. Aamir Rehman joins Mercer as Senior Physician Strategy Consultant investment picks
Roos Honored for Her Work in South Africa and Other Regions of the World to Develop Sustainable Animal Health Care Programs for Indigenous, Indigent Communities and for Advancing the One Health Concept MELVILLE, N.Y. , Oct.
Sign-up for Dr. Annelize Roos Receives The Second Annual Henry Schein Cares International Veterinary Community Service Award At The 39th World Small Animal Veterinary Association Congress investment picks
CHARLOTTE, N.C., Sept.
Sign-up for Dr. Bimal Shah Joins Premier, Inc. to Lead Healthcare Improvement Research investment picks
Alere Analytics , an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced that Chief Medical Officer and Co-founder, Dr.
Sign-up for Dr. Fauzia Khan, CMO of Alere Analytics, to Provide Healthcare Insights on Population Health Management and the Next Generation of ACOs at the US News & World Report Hospital of Tomorrow Conference investment picks
Magellan Health, Inc. (NASDAQ: MGLN) today announced that Dr.
Sign-up for Dr. John O. Agwunobi Appointed to Magellan Health Board of Directors investment picks
Greenwood Hall, Inc. (OTCBB: ELRN), education technology provider of dynamic student lifecycle management solutions for colleges and universities, today announced that Dr.
Sign-up for Dr. John R. Hall Featured Keynote Speaker at TechOut LA investment picks
Greenwood Hall, Inc. (OTCBB: ELRN), education technology provider of dynamic student lifecycle management solutions for colleges and universities, today announced that Dr.
Sign-up for Dr. John R. Hall to Serve as Featured Panelist at Educause 2014 investment picks
Renowned Nephrologist to Head Up Hospital Services Group DENVER , Oct.
Sign-up for Dr. John Wigneswaran Joins Team at DaVita Kidney Care investment picks
http://media.marketwire.com/attachments/201310/67642_Quidel_RGB_.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1159881&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for Dr. Kenneth J. Widder Joins Quidel's Board of Directors investment picks
CLO Oversees All Medical, Clinical Operations for DaVita Labs DELAND, Fla.
Sign-up for Dr. Lorne Holland Joins DaVita Labs as Chief Lab Officer investment picks
Alere Analytics , an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced that Chief Executive Officer and Co-founder, Dr.
Sign-up for Dr. Mansoor Khan, CEO of Alere Analytics, to Share Vision on the Future of Big Data & Predictive Analytics at Boston Children’s Hospital Global Pediatric Innovation Summit investment picks
Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2014 on Wednesday, October 29, 2014 after the Board Meeting.
Sign-up for Dr. Reddy's to Release Q2 FY15 Results on October 29, 2014 investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE ® (docetaxel Injection) in the US market on November 21, 2014.
Sign-up for Dr. Reddy’s Announces the Launch of Docetaxel Injection USP investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Levalbuterol Inhalation Solution, USP 0.31 mg /3 mL, 0.63 mg /3 mL, 1.25 mg / 3 mL Unit-Dose Vials, a therapeutic equivalent generic version of XOPENEX® (levalbuterol hydrochloride) inhalation solution in the US market on September 23, 2014, approved by the United States Food & Drug Administration (USFDA). The XOPENEX® (levalbuterol hydrochloride) inhalation solution brand and generic combined had U.S. sales of approximately $269.7 Million MAT for the most recent twelve months ending in June 2014 according to IMS Health*. Dr.
Sign-up for Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a bioequivalent generic version of Allegra-D® 12 Hour Allergy & Congestion, in the U.S. market on November 18, 2014.
Sign-up for Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets investment picks
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE ® (Sirolimus) tablets in the US market on October 27, 2014, following the approval by the United States Food & Drug Administration (USFDA). The RAPAMUNE ® tablets brand had U.S. sales of approximately $206 Million MAT for the most recent twelve months ending in August 2014 according to IMS Health*. Dr.
Sign-up for Dr. Reddy’s Announces the Launch of Sirolimus Tablets, 1 mg and 2 mg investment picks
Dr. Reddy’s Laboratories Ltd.
Sign-up for Dr. Reddy’s Q2 and H1 FY15 Financial Results investment picks
2014/9/24
Susan Groenwald, PhD, RN, ANEF, president of Chamberlain College of Nursing , is to be inducted as a fellow of the American Academy of Nursing (Academy) at the Academy’s annual conference in Washington, D.C., on Oct.
Sign-up for Dr. Susan Groenwald to be Inducted as Fellow of the American Academy of Nursing investment picks
2014/12/2
DRA CRT Acquisition Corp.
Sign-up for DRA CRT Acquisition Corp. Announces Redemption on January 2, 2015 of Its 8-1/2% Series A Cumulative Redeemable Preferred Stock investment picks
2014/11/20
DRA CRT Acquisition Corp.
Sign-up for DRA CRT Acquisition Corp. Declares Quarterly Dividend on Preferred Stock investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Dr Pepper Snapple Group Announces Appointment of Director to DRA CRT Acquisition Corp. Declares Quarterly Dividend on Preferred Stock
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent